These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1672621

  • 1. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
    Freeman JW, McGrath P, Bondada V, Selliah N, Ownby H, Maloney T, Busch RK, Busch H.
    Cancer Res; 1991 Apr 15; 51(8):1973-8. PubMed ID: 1672621
    [Abstract] [Full Text] [Related]

  • 2. Proliferation-associated nucleolar antigen P120: a prognostic marker in node-negative breast cancer.
    McGrath PC, Holley DT, Hamby LS, Powell DE, Mattingly C, Freeman JW.
    Surgery; 1994 Oct 15; 116(4):616-20; discussion 20-1. PubMed ID: 7940158
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 4. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA.
    Cancer Res; 1991 Jan 15; 51(2):556-67. PubMed ID: 1670762
    [Abstract] [Full Text] [Related]

  • 5. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 6. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.
    Giai M, Roagna R, Ponzone R, De Bortoli M, Dati C, Sismondi P.
    Anticancer Res; 1994 Mar 15; 14(3B):1441-50. PubMed ID: 7915096
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR.
    Cancer Res; 2002 Jun 15; 62(12):3417-27. PubMed ID: 12067984
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
    Crowe JP, Gordon NH, Hubay CA, Shenk RR, Zollinger RM, Brumberg DJ, McGuire WL, Shuck JM.
    Surg Gynecol Obstet; 1991 Oct 15; 173(4):273-8. PubMed ID: 1925896
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
    Schimmelpenning H, Eriksson ET, Falkmer UG, Rutqvist LE, Johansson H, Fallenius A, Auer GU.
    Eur J Surg Oncol; 1992 Dec 15; 18(6):530-7. PubMed ID: 1362164
    [Abstract] [Full Text] [Related]

  • 10. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A, International Breast Cancer Study Group.
    Cancer; 2003 Apr 01; 97(7):1591-600. PubMed ID: 12655514
    [Abstract] [Full Text] [Related]

  • 11. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Apr 01; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 12. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL.
    Clin Cancer Res; 2003 Feb 01; 9(2):594-600. PubMed ID: 12576423
    [Abstract] [Full Text] [Related]

  • 13. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, Ross JS.
    Mod Pathol; 2000 May 01; 13(5):542-7. PubMed ID: 10824926
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 15. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G, Maesawa C, Mikawa S, Satodate R.
    Jpn J Clin Oncol; 1991 Aug 12; 21(4):264-7. PubMed ID: 1682519
    [Abstract] [Full Text] [Related]

  • 16. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
    Pavelic ZP, Pavelic L, Lower EE, Gapany M, Gapany S, Barker EA, Preisler HD.
    Cancer Res; 1992 May 01; 52(9):2597-602. PubMed ID: 1348967
    [Abstract] [Full Text] [Related]

  • 17. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
    Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7147-52. PubMed ID: 2573426
    [Abstract] [Full Text] [Related]

  • 18. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 19. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.
    Cancer; 2003 Feb 01; 97(3):545-53. PubMed ID: 12548595
    [Abstract] [Full Text] [Related]

  • 20. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.
    J Clin Oncol; 2007 Oct 01; 25(28):4423-30. PubMed ID: 17906205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.